$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Many Investors Wouldn't Touch This Stock With a 10-Foot Pole Last Year. Here's Why It's a Buy in 2023.
05:30am, Friday, 06'th Jan 2023
Moderna's vaccine earnings are helping it prepare for the future.
CytomX shares surge more than 50% on Moderna partnership
05:11pm, Thursday, 05'th Jan 2023
CytomX Therapeutics Inc. CTMX, +7.19% shares soared more than 50% in the extended session Thursday after the small biotech company announced a partnership with Moderna Inc. MRNA, -2.17% CytomX shares
Moderna Buying Genomics K.K. For $85 Million (MRNA)
08:35am, Thursday, 05'th Jan 2023
Moderna (MRNA) announced it is buying OriCiro Genomics K.K. These are the details.
Moderna to buy Japan-based OriCiro Genomics for US$85M
10:05am, Wednesday, 04'th Jan 2023
Moderna Inc, the biotech pioneering messenger RNA (mRNA) therapeutics and vaccines, said it has struck a deal to buy Japan-based OriCiro Genomics for US$85 million to boost its manufacturing capabilit
Moderna Bolsters Its Vaccine Pipeline With $85 Million Deal for Biotech Firm OriCiro
10:01am, Wednesday, 04'th Jan 2023
The small Tokyo-based company's tools will help the pharma giant's messenger RNA manufacturing process.
100 Best Stocks Of 2022: Oil Stocks And Medicals Shine
06:00pm, Friday, 30'th Dec 2022
Medical and energy companies, including oil stocks, lead the list of the 100 best stocks in 2022. The post 100 Best Stocks Of 2022: Oil Stocks And Medicals Shine appeared first on Investor's Business
Tesla is not alone: 18 (and a half) other big stocks are headed for their worst year on record
07:59pm, Thursday, 29'th Dec 2022
In the worst year for stocks since the Great Recession, several big names are headed for their worst year on record with just one trading day left in 2022.
These Are The 5 Best Dow Jones Stocks For 2022
01:07pm, Thursday, 29'th Dec 2022
Biotechs, insurers and heavy equipment were among the best Dow Jones stocks for 2022. An oil stock led, even though oil prices declined.
Biotech: 3 Profitable Bios Worth Owning
03:22pm, Wednesday, 28'th Dec 2022
The biotechnology space can be a difficult area to generate profits. Drugs take years to develop and often fail FDA approval.
Jefferies analyst reveals his top two biotech stocks for 2023
07:26pm, Tuesday, 27'th Dec 2022
Moderna Inc (NASDAQ: MRNA) has tanked nearly 15% in recent days but a Jefferies analyst dubs it one of his best ideas for 2023. Moderna stock could climb another 50% Earlier in December, the biotech c
Stock Market Gets More Jittery As Bond Yields Jump Again; Sellers Hit Tesla, Moderna, Nvidia Hard
05:41pm, Tuesday, 27'th Dec 2022
The stock market held up relatively well Tuesday, except for technology stocks, which fell hard as the 10-year Treasury yield spiked again. The post Stock Market Gets More Jittery As Bond Yields Jump
This Stock Just Soared by 20%: Should You Buy Now?
08:30am, Monday, 26'th Dec 2022
It's been an otherwise poor year for this biotech on the stock market.
Biotech is Set for a Blockbuster 2023: Here's Why
11:17am, Friday, 23'rd Dec 2022
The biotech sector has been outperforming the major U.S. indices for the past few months. Can the strength continue?
Here's Where to Invest $1,000 Right Now
06:00am, Friday, 23'rd Dec 2022
The investing year isn't over yet
Moderna agrees 10-year vaccine manufacturing deal with UK
11:06am, Thursday, 22'nd Dec 2022
Moderna has agreed to invest in a Covid vaccine research and development and build a new vaccine manufacturing facility in the UK. “The deal is also a major boost for UK health research and will see
Sign In
Buy MRNA